tiprankstipranks
AdAlta Ltd. (AU:1AD)
ASX:1AD
Australian Market

AdAlta Ltd. (1AD) Price & Analysis

Compare
4 Followers

1AD Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

0.27%99.73%
― Other Institutional Investors
99.73% Public Companies and
Individual Investors

1AD FAQ

What was AdAlta Ltd.’s price range in the past 12 months?
AdAlta Ltd. lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
    What is AdAlta Ltd.’s market cap?
    AdAlta Ltd.’s market cap is AU$9.48M.
      When is AdAlta Ltd.’s upcoming earnings report date?
      AdAlta Ltd.’s upcoming earnings report date is Aug 22, 2025 which is in 180 days.
        How were AdAlta Ltd.’s earnings last quarter?
        AdAlta Ltd. released its earnings results on Feb 20, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
          Is AdAlta Ltd. overvalued?
          According to Wall Street analysts AdAlta Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does AdAlta Ltd. pay dividends?
            AdAlta Ltd. does not currently pay dividends.
            What is AdAlta Ltd.’s EPS estimate?
            AdAlta Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does AdAlta Ltd. have?
            AdAlta Ltd. has 632,111,630 shares outstanding.
              What happened to AdAlta Ltd.’s price movement after its last earnings report?
              AdAlta Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of AdAlta Ltd.?
                Currently, no hedge funds are holding shares in AU:1AD
                ---

                AdAlta Ltd. Stock Smart Score

                Company Description

                AdAlta Ltd.

                AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Biotron Limited
                Neuren Pharmaceuticals Limited
                Patrys Limited
                Immutep Ltd
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis